Transnational Cannabis Ltd Stock Price To Earning
| TRCNF Stock | USD 0 0.00 0.00% |
Fundamental analysis of TRANSNATIONAL CANNABIS allows traders to better anticipate movements in TRANSNATIONAL CANNABIS's stock price by examining its financial health and performance throughout various phases of its business cycle.
TRANSNATIONAL |
TRANSNATIONAL CANNABIS LTD Company Price To Earning Analysis
TRANSNATIONAL CANNABIS's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, TRANSNATIONAL CANNABIS LTD has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
TRANSNATIONAL Fundamentals
| Return On Equity | -1.77 | |||
| Return On Asset | -0.58 | |||
| Current Valuation | 25.08 M | |||
| Shares Outstanding | 706.11 M | |||
| Price To Book | 0 X | |||
| Gross Profit | (17.75 M) | |||
| EBITDA | (59.92 M) | |||
| Net Income | (60.31 M) | |||
| Cash And Equivalents | 651.92 K | |||
| Total Debt | 3.98 M | |||
| Debt To Equity | 0.69 % | |||
| Current Ratio | 2.83 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (7.92 M) | |||
| Earnings Per Share | (0.21) X | |||
| Beta | -123.5 | |||
| Market Capitalization | 70.61 K | |||
| Total Asset | 69.76 M | |||
| Net Asset | 69.76 M |
About TRANSNATIONAL CANNABIS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TRANSNATIONAL CANNABIS LTD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TRANSNATIONAL CANNABIS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TRANSNATIONAL CANNABIS LTD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VOO | Vanguard SP 500 | |
| XLK | Technology Select Sector | |
| XLV | Health Care Select | |
| QQQ | Invesco QQQ Trust | |
| XLC | Communication Services Select |
Other Information on Investing in TRANSNATIONAL Pink Sheet
TRANSNATIONAL CANNABIS financial ratios help investors to determine whether TRANSNATIONAL Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TRANSNATIONAL with respect to the benefits of owning TRANSNATIONAL CANNABIS security.